Literature DB >> 12004275

High prevalence of HIV-1 subtype G and natural polymorphisms at the protease gene among HIV-infected immigrants in Madrid.

Africa Holguín1, Amparo Alvarez, Vincent Soriano.   

Abstract

OBJECTIVES: Genetic characterization of HIV-1 subtypes among immigrants and natives infected overseas.
METHODS: Phylogenetic analysis of HIV-1 protease sequences obtained from 109 foreigners (mainly Africans) and 32 native individuals infected overseas attending a reference HIV/AIDS centre located in Madrid, Spain.
RESULTS: The overall rate of infection with HIV-1 non-B subtypes was 50.3% (71/141). Whereas 94.3% (67/71) belonged to immigrants (mostly Africans, 60/67), only 5.6% (4/71) were from native individuals (P < 0.05). The distribution of non-B subtypes was: 49 G, eight C, six A, four D, two F and two H. The high prevalence of subtype G was mainly related to individuals from west-central Africa. Interestingly, substitutions at three or more positions associated with protease inhibitor (PI) resistance were recognized in 52.6% of naive subjects carrying non-B subtypes, but only in 8% of those infected with B viruses (P < 0.05). The genotypes most frequently recognized among non-B and B subtypes occurred, respectively, at positions 36 (100 versus 12%), 20 (77.2 versus 0%), 63 (40.3 versus 64%), 82 (17.5 versus 0%), 10 (14 versus 12%), 77 (3.5 versus 34%), and 71 (0 versus 2%). Accordingly, changes I-36 and I-20 may be considered specific genetic markers for non-B, group M variants and subtype G infections, respectively.
CONCLUSION: Nearly two-thirds of foreigners with HIV-1 infection in Madrid carry non-B subtypes, subtype G (protease) being the most common among west-central African immigrants. The high rate of natural polymorphisms at the protease gene in non-B viruses may compromise the response to PI. Therefore, HIV subtyping should be considered in treatment guidelines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12004275     DOI: 10.1097/00002030-200205240-00010

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  16 in total

1.  Effect of natural polymorphisms in the HIV-1 CRF02_AG protease on protease inhibitor hypersusceptibility.

Authors:  André F A Santos; Denis M Tebit; Matthew S Lalonde; Ana B Abecasis; Annette Ratcliff; Ricardo J Camacho; Ricardo S Diaz; Ottmar Herchenröder; Marcelo A Soares; Eric J Arts
Journal:  Antimicrob Agents Chemother       Date:  2012-02-13       Impact factor: 5.191

2.  Molecular surveillance of HIV-1 in Madrid, Spain: a phylogeographic analysis.

Authors:  José M González-Alba; Africa Holguín; Rosa Garcia; Silvia García-Bujalance; Roberto Alonso; Avelina Suárez; Rafael Delgado; Laura Cardeñoso; Rosa González; Isabel García-Bermejo; Francisca Portero; Carmen de Mendoza; Fernando González-Candelas; Juan-Carlos Galán
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

3.  Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy.

Authors:  Patrícia A Brindeiro; Rodrigo M Brindeiro; Cláudio Mortensen; Kurt Hertogs; Veronique De Vroey; Norma P M Rubini; Fernando S Sion; Carlos A M De Sá; Deisy M Machado; Regina C M Succi; Amilcar Tanuri
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

4.  Transmitted drug resistance in nonsubtype B HIV-1 infection.

Authors:  Philip A Chan; Rami Kantor
Journal:  HIV Ther       Date:  2009-09-01

5.  Protease polymorphisms in HIV-1 subtype CRF01_AE represent selection by antiretroviral therapy and host immune pressure.

Authors:  Weerawat Manosuthi; David M Butler; Josué Pérez-Santiago; Art Fy Poon; Satish K Pillai; Sanjay R Mehta; Mary E Pacold; Douglas D Richman; Sergei Kosakovsky Pond; Davey M Smith
Journal:  AIDS       Date:  2010-01-28       Impact factor: 4.177

6.  Diversity of human immunodeficiency virus type 1 subtype A and CRF03_AB protease in Eastern Europe: selection of the V77I variant and its rapid spread in injecting drug user populations.

Authors:  Nikita I Roudinskii; Anna L Sukhanova; Elena V Kazennova; Jonathan N Weber; Vadim V Pokrovsky; Vladimir M Mikhailovich; Aleksei F Bobkov
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

7.  Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B.

Authors:  Nicaise Ndembi; Awet Abraha; Heather Pilch; Hiroshi Ichimura; Dora Mbanya; Lazare Kaptue; Robert Salata; Eric J Arts
Journal:  J Clin Microbiol       Date:  2007-09-12       Impact factor: 5.948

8.  Reliability of rapid subtyping tools compared to that of phylogenetic analysis for characterization of human immunodeficiency virus type 1 non-B subtypes and recombinant forms.

Authors:  Africa Holguín; Marisa López; Vincent Soriano
Journal:  J Clin Microbiol       Date:  2008-10-08       Impact factor: 5.948

9.  HIV Genetic Diversity and Drug Resistance.

Authors:  André F Santos; Marcelo A Soares
Journal:  Viruses       Date:  2010-02-02       Impact factor: 5.818

10.  Description of HIV-1 group M molecular epidemiology and drug resistance prevalence in Equatorial Guinea from migrants in Spain.

Authors:  Gonzalo Yebra; Miguel de Mulder; África Holguín
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.